Pre-clinical evaluation of gadobutrol: a new, neutral, extracellular contrast agent for magnetic resonance imaging
- 30 November 1995
- journal article
- Published by Elsevier in European Journal of Radiology
- Vol. 21 (1) , 1-10
- https://doi.org/10.1016/0720-048x(95)00679-k
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Preclinical Safety Assessment and Pharmacokinetics of Gadodiamide Injection, a New Magnetic Resonance Imaging Contrast AgentInvestigative Radiology, 1993
- Summary of Preclinical Safety Evaluation of Gadoteridol InjectionInvestigative Radiology, 1992
- High‐dose gadoteridol in MR imaging of intracranial neoplasmsJournal of Magnetic Resonance Imaging, 1992
- Tolerance data of Gd-DTPA: a reviewEuropean Journal of Radiology, 1991
- Extravascular Toxicity of Two Magnetic Resonance Contrast AgentsInvestigative Radiology, 1991
- Functional cerebral imaging by susceptibility‐contrast NMRMagnetic Resonance in Medicine, 1990
- The relationship between thermodynamics and the toxicity of gadolinium complexesMagnetic Resonance Imaging, 1990
- Albumin binding of paramagnetic hepatobiliary contrast agents: Enhancement of outer sphere relaxivityInternational Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology, 1988
- An In Vitro Assay for Radiographic Contrast Media IdiosyncrasyInvestigative Radiology, 1980
- Major intravenous extravasation injuriesThe American Journal of Surgery, 1979